scorecardresearch
Monday, September 15, 2025
TopicPharma sector

Topic: Pharma sector

India to get 7 million doses of Moderna vaccine, but indemnity puts question mark on when

The central govt has so far procured only vaccines manufactured in India. But Moderna vaccine will be a part of the national vaccination programme.

Eli Lilly inks licensing deal with Cipla, Lupin, Sun Pharma for Baricitinib to treat Covid

Baricitinib is currently registered in India for the treatment of moderate to severe active rheumatoid arthritis in adult patients.

India-China flight disruptions could hurt global pharma supply chains

The US relies heavily on India to stock its medicine cabinets, and any slowdown in output could leave pharmacies short of drugs used regularly by millions of Americans.

India approaches US firms seeking investment in country’s pharmaceutical, medical sector

Last week, India's Ambassador to the US Taranjit Singh Sandhu held virtual meetings with top US pharma companies, including Pfizer, and said India is seeking to encourage investments.

Pharma industry warns of Covid drug shortages as raw materials prices surge 200%

Pharma firms say suspension of cargo from China has resulted hoarding, driving up prices of raw materials, seek govt intervention immediately.

Faced with drugs shortage, Indian pharma asks envoy to stop Chinese cargo suspension

On 26 April, China suspended for 15 days cargo flights by Sichuan Airlines that transports medical supplies to India. India imports 70% of its pharmaceutical raw materials from China.

Demand for Covid vaccines, hydroxychloroquine pushes India’s pharma exports to 5-year high

Exports are expected to rise by over 16% this fiscal. The industry recorded less than 3% growth in 2014-15 and 2017-18. In 2016-17, there was negative growth of 0.59%.

India ‘pharmacy to world’ but sector is fragmented, unorganised — foreign firms’ lobby says

Report highlights loopholes in distribution chain of pharma products, but also stresses on India’s important role in ‘promoting local and global health goals’.

Cipla, Sun Pharma, Lupin on drug price watchdog’s new list of firms ‘overcharging consumers’

NPPA has issued a list of  ‘overcharging cases’ under litigation, which includes matters dating back to 1997 & those where firms have moved court against the allegations.

To boost pharma investments, Modi govt sets up panel to revamp policies & draw up action plan

The expert panel, consisting of 5 members from the industry and a govt official, has highlighted archaic labour laws & flawed definitions of fast-tracking mechanisms as hiccups. 

On Camera

Manipur has seen too much pain to be seduced by promises

Nehru learned the truth the hard way when 3,000 Nagas walked out of his 1953 rally. The people of the Northeast aren’t easily seduced by baubles.

What’s behind bond yields’ logic-defying spike? The market’s concern over the future

While bond yields tend to fall amid low inflation & interest rate cuts, market experts say they’ve been rising due to concerns over tax collections, fiscal deficit & potential impact of US tariffs.

Navy gets first Tata-made Spanish 3D surveillance radar for its warships, 19 more to come

It is one of the most advanced long-range air defence and anti-missile radars. It has been acquired under an about USD 145-million deal signed in 2020.

Gen Zs have taken down the Nepal regime. Here’s why this will never happen in India

To be truly functional and durable, even eternal, a state doesn’t just need a leader, a party or an ideology. It needs functional and robust institutions.